VolitionRx Limited, a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has published a report with contributions from four global leaders in veterinary oncology, ahead of the expected launch of its first product, the Nu.Q™ Vet Cancer Screening Test.
November 10, 2020
· 7 min read